维普期刊资源整合服务平台（V6.5）

96篇 您的检索式：作者名="Mankoff DA"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thy- roid with functional imaging correlation 显示文摘	Carr LL Mankoff DA Goulart BH	2010	Clin Cancer Res2010，16，21：	1
2	Quantitative imaging of estrogen receptor expression in breast cancer with PET and SF-fluo- roestradiol显示文摘	Peterson LM Mankoff DA Lawton T	2008	J Nucl Med2008，49，3：	1
3	Tumor receptor imaging显示文摘	Mankoff DA Link JM Linden HM	2008	J Nucl Med2008，49，2：	1
4	Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjurant chemotherapy 显示文摘	Mankoff DA Dunnwald LK Gralow JR	2003	J Nucl Med2003，44，11：	1
5	FDG PET,PET/CT,and breast cancer imaging显示文摘	Rosen EL Eubank WB Mankoff DA	2007	Radiographics2007，27，1：	1
6	A definition of molecular imaging显示文摘	Mankoff DA	2007	Nuclear Med2007，48，6：	1
7	Changes in blood flow and metabolism in locally advancde breast eancer treated with neoadjuvant chemotherapy显示文摘	Mankoff DA Dunnwakd LK Gralow JR	2003	J Nucl Med2003，44，11：	1
8	Blood flow-metabolism mismatch: good for tumor, bad for the patient 显示文摘	Mankoff DA Dunnwald LK Partridge SC	2009	Clin Cancer Res2009，15，17：	1
9	Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant them otherapy 显示文摘	Mankoff DA Dunnwakd LK Gralow JR et el	2003	J Nucl Med2003，44，：	1
10	Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation显示文摘	Carr LL Mankoff DA Goulart BH	2010	Clinical Cancer Research2010，16，21：	1
11	FDG PET,PET/CT,and breast cancer imaging显示文摘	Rosen EL Eubank WB Mankoff DA	2007	Radiographics2007，，27：	1
12	Tumor metabolic rates in sarcoma using FDG PET显示文摘	Eary JF Mankoff DA	1998	J Nucl Med1998，39，：	1
13	Tumor-specific positron emission tomography imaging in patients: Fluorodeoxyglucose and Beyond显示文摘	Mankoff DA Eary JF Link JM	2007	Clin Cancer Res2007，13，：	1
14	Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience 显示文摘	Hathaway PB Mankoff DA Maravilla KR	1999	Radiology1999，210，3：	1
15	Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol显示文摘	Peterson LM Mankoff DA Lawton TJ	2008	J Nucl Med2008，49，：	1
16	How imaging can impact clinical trial design: molecular imaging as a biomarker for targeted cancer therapy显示文摘	Mankoff DA Farwell MD Clark AS	2015	Cancer J2015，21，3：	1
17	Tumor-specific positron emission tomography imaging in patients: ^18F-flnorodeoxyglucose and beyond显示文摘	Mankoff DA Eary JF Link JM	2007	Clin Cancer Res2007，13，12：	1
18	Evolving role of positron emission tomography in breast cancer imaging 显示文摘	Eubank WB Mankoff DA	2005	Semin Nucl Med2005，35，：	1
19	Phase Ⅱ study of daily sunitinib in FDG-PET-positive,iodine-refractory differentiated thyroid cancer and metastatic nedullary carcinoma of the thyroid with functional imaging correlation显示文摘	Carr LL Mankoff DA Goulart BH		0，，：	1
20	Tumor-specific positron emission tomography imaging in patients: lS F Fluorodeoxyglucose and Beyond 显示文摘	Mankoff DA Eary JF Link JM	2007	Clin Cancer Res2007，52，13：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示